Bernstein analyst Courtney Breen maintained a Hold rating on Amgen yesterday and set a price target of $335.00. The company’s shares closed yesterday at $367.79.
Bengaluru: British drugmaker GSK said on Friday the U.S. Food and Drug Administration has expanded the approved age range for ...
While I’ve never been overly superstitious, I admit I consciously avoid stepping on cracks. But I love a good adrenalin rush scare — the screaming thrill of a good roller coaster ride, watching a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results